Background: Genome-wide association studies have identified many susceptibility loci for obesity. However, missing heritability problem is still challenging and ignorance of genetic interactions is believed to be an important cause. Current methods for detecting interactions usually do not consider regulatory elements in non-coding regions. Interaction analyses within chromatin regulatory circuitry may identify new susceptibility loci. Methods: We developed a pipeline named interaction analyses within chromatin regulatory circuitry (IACRC), to identify genetic interactions impacting body mass index (BMI). Potential interacting SNP pairs were obtained based on Hi-C datasets, PreSTIGE (Predicting Specific Tissue Interactions of Genes and Enhancers) algorithm, and super enhancer regions. SNP × SNP analyses were next performed in three GWAS datasets, including 2286 unrelated Caucasians from Kansas City, 3062 healthy Caucasians from the Gene Environment Association Studies initiative, and 3164 Hispanic subjects from the Women's Health Initiative. Results: A total of 16,643,227 SNP × SNP analyses were performed. Meta-analyses showed that two SNP pairs, rs6808450-rs9813534 (combined P = 2.39 × 10 −9 ) and rs6808450-rs3773306 (combined P = 2.89 × 10
Introduction
Obesity is a worldwide health problem. It is associated with various diseases, particularly cardiovascular disease, type 2 diabetes and certain types of cancer. In addition, obesity is becoming more widespread and it is estimated that the number of obese individuals would be more than 1.12 billion by 2030 [1] . Genetic studies aimed to discover genetic variations that can be used in the prevention and treatment of obesity have drawn wide public concern.
Genome-wide association studies (GWASs) are extremely powerful to investigate the genetic architecture of complex diseases [2] . With the help of GWASs, many loci associated with obesity have been identified. However, These authors contributed equally: Shan-Shan Dong, Shi Yao. missing heritability, which is defined as the fact that variants identified so far can explain only a small proportion of the observed heritability of diseases, is still a big challenge. For example, with up to 339,224 individuals, Locke et al. [3] identified 97 body mass index (BMI)-associated loci, which only account for 2.7% of BMI variation. In contrast, the heritability of BMI was estimated as 40-70% [4, 5] . One significant limitation of GWASs is that it examines the effect of each locus independently. However, complex diseases often arise from genetic interactions [6] . In addition, ignorance of genetic interactions is believed to be an important cause for a substantial proportion of the missing heritability in studies of complex diseases/traits [7] . Therefore, researchers have tried to detect epistasis. However, interaction analyses using SNPs in the whole genome usually suffer from the problem of a very stringent significance [8] . Therefore, it is important to select regions of interest to discover the association signal. To solve this problem, previous studies usually restricted the search to a few candidate genes [9, 10] , risk SNPs that had weak marginal effects [11, 12] , known GWAS hits, protein-protein interactions, or pathway information [13] . However, none of them have specifically considered the interactions between regulatory elements in non-coding regions and their target genes.
Recently, with the release of regulatory data from Encyclopedia of DNA Elements (ENCODE) [14] and Roadmap Epigenomics Project [15] , researchers began to realize the importance of regulatory elements in non-coding regions. Diseases associated with susceptibility SNPs identified by GWASs are found to be enriched in cellspecific regulatory elements, mostly enhancers [16, 17] . Of the heritability explained by susceptibility SNPs identified by GWASs, SNPs in regulatory elements were estimated to account for 79% of the variance [18] . Variants in enhancers often regulate target gene expression through long-range interaction [19] . In addition, analyses of 3D genomic architecture showed that enhancers within a gene's regulatory circuitry can physically interact with one another and collectively regulate the expression of the target gene [20] . Considering the important roles of enhancers for genetic predisposition to diseases, it is possible that interaction analyses within chromatin regulatory circuitry may identify new susceptibility loci for obesity.
In this study, we developed a pipeline named interaction analyses within chromatin regulatory circuitry (IACRC), to identify genetic interactions impacting BMI. IACRC would automatically select chromatin regulatory circuit regions with Hi-C datasets, PreSTIGE (Predicting Specific Tissue Interactions of Genes and Enhancers) algorithm [21] , or super enhancer regions [22] . SNP × SNP interaction analyses were then performed in regions within chromatin regulatory circuits. Our results would identify novel genes that may contribute to the development of obesity. The pipeline can also be used to detect epistasis within chromatin regulatory circuitry for other complex diseases.
Materials and methods

GWAS datasets
Three GWAS datasets were used. Basic characteristics for samples in all datasets are listed in Table 1 . The first dataset (KCS) comprises 2286 unrelated US Caucasians of Northern European origin living in Kansas City and its surrounding areas. The description of this study has been detailed in our previous study [23] . The second dataset was downloaded from the Database of Genotypes and Phenotypes (dbGaP) with the accession number of phs000091.v2. p1. This study is part of the Gene Environment Association Studies initiative that aimed to identify genetic factors that contribute to type 2 diabetes mellitus (GENEVA_T2D). Data from 3062 healthy Caucasian controls were used in our analyses. The third dataset was also downloaded from the dbGaP database and the accession number is phs000386.v7.p3. This dataset belongs to the Women's Health Initiative (WHI) project and we used the data from 3164 Hispanic subjects in our analyses. The genotyping platform for all three datasets was the Affymetrix 6.0 array.
Acquisition of potential interacting regions
The outline of the current study is shown in Fig. 1 . An inhouse python script, which can be freely downloaded from the web resource (https://github.com/studentyaoshi/IACRC/), was used to obtain potential interacting regions within chromatin regulatory circuits meeting one of the following conditions. Firstly, Hi-C chromatin interacting regions for the obesity relevant cells were downloaded from published Table S1 ) were obtained from the Roadmap database to get the enhancer region information and annotate the interacting regions. We collected Hi-C interactions for which there was a protein coding gene in one locus that was paired to an enhancer in the other. These pairs were further used to collect enhancers that were associated with the same target gene.
We also collected interactions with both loci annotated as enhancers. Secondly, The PreSTIGE algorithm [21] was used to predict enhancer-gene interactions from disease relevant cells. We set the threshold that maximizes the number of predictions made while maintaining an estimated positive prediction rate >60%, i.e., the Shannon entropy Q score had to be below 6.1 for the enhancer and below 6.8 for the gene paired to that enhancer [21] . Enhancer pairs with same target genes were also collected. Thirdly, super-enhancers previously defined for disease relevant cells/tissues [22] were also used. All genes within 100 kb of super-enhancers were defined as putative target genes. Interactions may also occur within the super-enhancer region. We used data from the GM12878 cell line to obtain Hi-C [24] [25] [26] [27] and PreSTIGEbased interacting regions. Data for obesity relevant tissues/cells (supplementary Table S2 ) were used to obtain super-enhancer-based interacting regions. The interacting regions supported by at least one method were used in subsequent analyses.
Acquisition of SNP pairs and SNP pruning
After interacting region collections, SNP pairs were obtained from these interacting regions by using an inhouse script that can also be downloaded from the web resource. SNP quality control was then performed with the following criteria: individual missing rate <5%, SNP call rate >95%, minor allele frequency (MAF) > 5%, and Hardy-Weinberg equilibrium (HWE) P-value > 0.001. SNP pairs with two SNPs in linkage disequilibrium (LD, r 2 > 0.1) with each other were removed.
SNP × SNP interaction analyses and meta-analyses
SNP × SNP interaction analyses were finally performed by using the regression function (linear regression for quantitative trait and logistic regression for qualitative trait) in R (version 3.3.2) for the remaining SNP pairs. For each population, the principal components were calculated by using the GCTA software [28] . The first five principal components, age, and sex were used as potential covariates. Finally, the METAL software [29] was used to combine SNP × SNP interaction results obtained from different populations. We used the Bonferroni correction method [30] to account for the multiple testing problems, i.e., the significant threshold was set as 0.05/(number of SNP pairs).
Differential expression analysis
The Gene Expression Omnibus (GEO) dataset GSE76131 was used to check whether the identified susceptibility 
Genetically modified animals used for functional validation
We used the International Mouse Phenotyping Consortium (IMPC) database, which aims to discover the biological functions of every protein-coding gene through generating null alleles in mice on a C57BL/6 genetic background [31] , for the functional investigation of identified susceptibility genes by our pipeline.
Results
SNP × SNP interaction analyses
Detail statistics of intermediate stages are shown in Fig. 2 . A total of 16,643,227 SNP × SNP analyses were performed and the significant threshold after multiple testing correction was set as combined P < 3.0 × 10 −9 .
Meta-analyses results showed that two SNP pairs, rs6808450-rs9813534 (combined P = 2.39 × 10 −9
) and rs6808450-rs3773306 (combined P = 2.89 × 10 −9 ) were associated with BMI after multiple testing corrections ( Table 2 ). However, single-SNP analyses did not detect significant association signals for these three SNPs (P > 0.05, supplementary Table S3 ). Rs9813534 and rs3773306 are in high LD with each other, with the r 2 of 0.97, 0.97, and 0.80 in KCS, GENEVA_T2D, and WHI, respectively. We further checked whether the effect of the minor allele "C" of rs9813534 on BMI was different between subjects carrying different rs6808450 genotypes by using the beta coefficient. As shown in supplementary Figure S1A , in all three populations, the "C" allele was positively associated with BMI in subjects carrying "CC" genotypes of rs6808450. However, in subjects carrying "TT" genotypes of rs6808450, the "C" allele of rs9813534 was negatively associated with BMI. Similarly, the minor "C" allele of rs3773306 was also positively associated with BMI in subjects carrying "CC" genotypes of rs6808450 but negatively associated with BMI in subjects carrying "TT" genotypes of rs6808450 (supplementary Figure S1B ).
Differential expression analysis
As shown in Fig. 3 , in obesity relevant cells, rs6808450 is located in intergenic enhancers, while rs9813534 and rs3773306 are located in the region of strong transcription regions of CAND2 and RPL32, respectively. Therefore, CAND2 and RPL32 are the target genes in regulatory circuits and they may be new obesity susceptibility genes.
We next checked whether CAND2 and RPL32 were differentially expressed during the differentiation of SGBS Note: Only the significant SNP pairs after multiple testing corrections are shown
Location1 the located region/gene of SNP1, Location2 the located region/gene of SNP2, KCS Kansas City study, GENEVA_T2D Gene Environment Association Studies initiative that aimed to identify genetic factors that contribute to type 2 diabetes mellitus, WHI Women's Health Initiative, Combined P meta-analyses results by using all three GWAS samples cells. The results showed that only the expression of CAND2 was significantly downregulated after the differentiation of SGBS (Fig. 4 , P = 0.0241).
Functional validation in IMPC
Information from the IMPC database further supported the functional involvement of CAND2 in obesity. This gene is associated with increased lean body mass and decreased total body fat amount (http://www.mousephenotype.org/data/ genes/MGI:1914338#section-associations) in mice model.
Code availability
IACRC: https://github.com/studentyaoshi/IACRC.
Discussion
Considering the important roles of enhancers for genetic predisposition to diseases, here we developed a pipeline named IACRC, to perform interaction analyses within chromatin regulatory circuits for BMI. We identified two significant interaction pairs associated with BMI, rs6808450-rs9813534 and rs6808450-rs3773306. The relationships between these SNPs and obesity or other diseases have not been reported by previous GWASs before. According to the annotation results, CAND2 and RPL32 are the target genes in regulatory circuits. Further differential expression analyses in SGBS cells and functional validation in the mice model suggested CAND2 may be a novel obesity susceptibility gene. However, the relationship between RPL32 and obesity were not further validated. Since rs9813534 and rs3773306 are in high LD with each other, it is possible that the interaction between rs6808450 and rs3773306 was detected due to LD. CAND2 is located on chromosome 3p25.2 (chr3:12838171-12876313, Reference GRCh37.p13 Assembly) and encodes TATA-binding protein-interacting protein 120B (TIP120B). The association between CAND2 and obesity or BMI has not been reported before. A previous study revealed that TIP120B could inhibit the ubiquitination of myogenin through binding to Cullin1, resulting in the stabilization of myogenin and acceleration of the myogenic differentiation process [32] . In addition, our analyses using SGBS cells showed that CAND2 was downregulated after the differentiation of human SGBS cells, suggesting that it might suppress the adipogenesis process. Since the imbalance between adipose and muscle mass is a hallmark of obesity [33] , it is possible that CAND2 might be associated with obesity through promoting myogenesis and suppressing adipogenesis.
Limitations of the current study should be addressed. Since the current Hi-C and PreSTIGE data for obesity relevant cell/tissues are still limited, so we only used the Hi-C and PreSTIGE data from the GM12878 cell line to collect interacting regions in these two conditions. When data for other obesity relevant cell/tissues are available, other interactions associated with BMI may be detected with the IACRC pipeline.
In summary, in this study, we developed IACRC to perform interaction analyses within chromatin regulatory circuitry and identify genetic interactions impacting BMI. We identified two SNP pairs, rs6808450-rs9813534 and rs6808450-rs3773306 were associated with BMI after multiple testing corrections. Further annotation, differential expression analysis, and functional validation results supported that CAND2 may be a novel obesity susceptibility gene. We hope IACRC could facilitate interaction analyses and identify new genetic interactions for other complex diseases.
